70.919 Allowing Timely Access to Pain Medications in Discharged Hospital and Ambulatory Surgery Patients The Medical Society of the State of New York shall advocate for legislation and/or regulation prohibiting health insurers in New York from requiring preauthorization for prescribed opioid pain medicine for post-surgery and post-hospital discharged patients for an initial 7-day supply, and
70.920 Requiring Insurances to Apply Discounts That the Medical Society of the State of New York advocate for legislation or other appropriate means to ensure that all payments made by patients for prescription medications outside of their insurance coverage (such as pharmaceutical discount programs) count towards that patient’s annual deductible and out of pocket maximum,
70.921 Addressing Problems in Retail Pharmacies The Medical Society of the State of New York (MSSNY) collaborate with organizations representing independent pharmacies to advise state policymakers on the wide range of pharmacy problems including correcting pharmacy routines and systems that create inefficiency, confusion, unfairness and barriers to patient access. (HOD 2024-103, referred to Council; substitute
70.922 Transparency at the pharmacy counter – Let patients own their prescriptions. The Medical Society of the State of New York (MSSNY) supports legislation and/or regulation that enhances transparency in pharmacy drug costs, and availability, as well as alteration of the physician’s original prescription. MSSNY supports legislation and/or regulation to establish a mechanism for prescribers
70.951: Electronic Prescription for Controlled Substances: SUNSET HOD 2023 MSSNY supports use of electronic prescriptions for controlled substances and termination of the requirement for “hard copy” prescriptions, unless an exception to the e-prescribing mandate applies. (HOD 2013-106)
70.925 Mandating Child-proof Packaging on Marijuana Products Sold Legally in New York State The Medical Society of the State of New York will advocate for legislation or regulation mandating all cannabinoid products sold legally by licensed marijuana dispensaries in the State of New York to be sold to consumers in child-resistant packaging. (HOD 2023-154)
70.924 Methadone as Medication for Opioid Use Disorder in Community Settings MSSNY will support pilot projects on expansion of office-based methadone treatment for OUD outside OTPs when prescribed by addiction specialists and dispensed at local pharmacies with appropriate training and safeguards in place. (HOD 2023-155)
70.923 Retire Current NYS I-STOP Prescription Drug Monitoring Program and Transition to the Multistate PMP System The Medical Society of the State of New York will advocate to the New York State Department of Health for full integration access to multistate database in New York State Prescription Monitoring Program (PMP). MSSNY will also advocate for
70.999 Generic Drug Prescription Forms: MSSNY is in favor, whenever possible, of reducing the cost of care to the patient. Understanding that the freedom of the physician to specify a brand name remains inviolable and accepting the value of the freedom from liability incorporated in a 1982 generic drug substitution legislative proposal, The MSSNY adopted
70.998 Generic Drug Substitution: The members of the Medical Society of the State of New York are as interested as any other group of citizens in the State, if not more so, in eliminating unnecessary costs in the delivery of health care and are actively engaged in developing measures that will lead to the most
